Co-Authors
This is a "connection" page, showing publications co-authored by WEN-JEN HWU and CARLOS ANTONIO TORRES CABALA.
Connection Strength
1.021
-
Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma. Arch Med Res. 2020 11; 51(8):827-838.
Score: 0.744
-
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma. Hum Pathol. 2015 Aug; 46(8):1101-10.
Score: 0.128
-
Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy. Am J Dermatopathol. 2014 Jul; 36(7):557-61.
Score: 0.121
-
Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor. Am J Dermatopathol. 2013 Feb; 35(1):125-8.
Score: 0.027